Dyne Therapeutics logo

Dyne Therapeutics Share Price (NASDAQ: DYN)

$13.73

0.09

(0.66%)

Last updated on

Check the interactive Dyne Therapeutics Stock chart to analyse performance

Dyne Therapeutics stock performance

as on August 29, 2025 at 1:29 am IST

  • Today's Low:$13.64
    Today's High:$14.12

    Day's Volatility :3.4%

  • 52 Weeks Low:$6.36
    52 Weeks High:$46.26

    52 Weeks Volatility :86.25%

Dyne Therapeutics Stock Returns

PeriodDyne Therapeutics, IncSector (Health Care)Index (Russel 2000)
3 Months
14.05%
4.2%
0.0%
6 Months
0.22%
-8.0%
0.0%
1 Year
-69.86%
-12.1%
0.0%
3 Years
35.18%
7.6%
-6.9%

Dyne Therapeutics, Inc Key Stats

Check Dyne Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$13.64
Open
$13.64
Today's High
$14.12
Today's Low
$13.64
Market Capitalization
$1.9B
Today's Volume
$2.2M
52 Week High
$46.26
52 Week Low
$6.36
Revenue TTM
$0.0
EBITDA
$-439.0M
Earnings Per Share (EPS)
$-3.88
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-61.32%

Stock Returns calculator for Dyne Therapeutics Stock including INR - Dollar returns

The Dyne Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Dyne Therapeutics investment value today

Current value as on today

₹34,935

Returns

₹65,065

(-65.07%)

Returns from Dyne Therapeutics Stock

₹69,496 (-69.5%)

Dollar Returns*

₹4,430 (+4.43%)

Indian investors sentiment towards Dyne Therapeutics Stock

33%

Period: Jul 29, 2025 to Aug 28, 2025. Change in 30 Days versus previous period

Search interest for Dyne Therapeutics Stock from India on INDmoney has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Dyne Therapeutics, Inc

  • Name

    Holdings %

  • RA Capital Management, LLC

    6.83%

  • HHG PLC

    6.63%

  • BlackRock Inc

    5.66%

  • Vanguard Group Inc

    5.38%

  • FCPM III SERVICES BV

    3.84%

  • FMR Inc

    3.65%

Analyst Recommendation on Dyne Therapeutics Stock

Rating
Trend

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Dyne Therapeutics(by analysts ranked 0 to 5 stars)

Dyne Therapeutics Share Price Target

What analysts predicted

Upside of 157.49%

Target:

$35.35

Current:

$13.73

Dyne Therapeutics share price target is $35.35, a slight Upside of 157.49% compared to current price of $13.73 as per analysts' prediction.

Dyne Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, DYN stock has moved up by 11.6%
  • DYN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.8% return, outperforming this stock by 131.5%
  • DYN vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 115.3% return, outperforming this stock by 84.0%

Dyne Therapeutics Technicals Summary

Sell

Neutral

Buy

Dyne Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Dyne Therapeutics, Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Dyne Therapeutics, Inc logo
48.26%
0.22%
-69.86%
35.18%
-42.93%
Regeneron Pharmaceuticals, Inc. logo
5.16%
-16.0%
-50.21%
-0.24%
-5.32%
Beone Medicines Ltd logo
-1.83%
10.43%
51.2%
81.32%
24.25%
Vertex Pharmaceuticals Incorporated logo
-16.94%
-18.91%
-21.14%
38.29%
39.4%
Alnylam Pharmaceuticals, Inc. logo
37.4%
84.06%
58.25%
116.31%
242.42%

Dyne Therapeutics Dividend announcements

  • Dyne Therapeutics Earnings

    Dyne Therapeutics’s price-to-earnings ratio stands at None

About Dyne Therapeutics, Inc

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Organization
Dyne Therapeutics
Employees
206
CEO
Mr. John G. Cox M.B.A.
Industry
Commercial Services

Key Management of Dyne Therapeutics, Inc

NameTitle
Mr. John G. Cox M.B.A.
CEO, President & Director
Dr. Oxana Beskrovnaya Ph.D.
Chief Innovation Officer
Ms. Johanna Friedl-Naderer
Chief Commercial Officer
Dr. Douglas Kerr M.B.A., M.D., Ph.D.
Chief Medical Officer
Mr. Erick J. Lucera C.F.A., CPA
CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer
Dr. Rajesh Manchanda Ph.D.
Chief Technical Officer
Mr. James P. Bilotta M.B.A.
Chief Digital & Information Officer
Dr. Ranjan Batra Ph.D.
Chief Scientific Officer
Mr. Daniel Wilson
Senior VP & Head of Legal
Ms. Lucia Celona
Chief Human Resource Officer

Important FAQs about investing in DYN Stock from India :

What is Dyne Therapeutics share price today?

Dyne Therapeutics share price today is $13.73 as on at the close of the market. Dyne Therapeutics share today touched a day high of $14.12 and a low of $13.64.

What is the 52 week high and 52 week low for Dyne Therapeutics share?

Dyne Therapeutics share touched a 52 week high of $46.26 and a 52 week low of $6.36. Dyne Therapeutics stock price today i.e. is closed at $13.73, lower by 70.32% versus the 52 week high.

How to invest in Dyne Therapeutics Stock (DYN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Dyne Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dyne Therapeutics Shares that will get you 0.1092 shares as per Dyne Therapeutics share price of $13.73 per share as on August 29, 2025 at 1:29 am IST.

What is the minimum amount required to buy Dyne Therapeutics Stock (DYN) from India?

Indian investors can start investing in Dyne Therapeutics (DYN) shares with as little as ₹87.6463 or $1 (as of August 29, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹876.46 in Dyne Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 29, 2025). Based on Dyne Therapeutics share’s latest price of $13.73 as on August 29, 2025 at 1:29 am IST, you will get 0.7283 shares of Dyne Therapeutics. Learn more about fractional shares .

What are the returns that Dyne Therapeutics has given to Indian investors in the last 5 years?

Dyne Therapeutics stock has given -42.93% share price returns and 18.6% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?